Literature DB >> 17630337

Current status of veterinary vaccines.

Els N T Meeusen1, John Walker, Andrew Peters, Paul-Pierre Pastoret, Gregers Jungersen.   

Abstract

The major goals of veterinary vaccines are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. These diverse aims have led to different approaches to the development of veterinary vaccines from crude but effective whole-pathogen preparations to molecularly defined subunit vaccines, genetically engineered organisms or chimeras, vectored antigen formulations, and naked DNA injections. The final successful outcome of vaccine research and development is the generation of a product that will be available in the marketplace or that will be used in the field to achieve desired outcomes. As detailed in this review, successful veterinary vaccines have been produced against viral, bacterial, protozoal, and multicellular pathogens, which in many ways have led the field in the application and adaptation of novel technologies. These veterinary vaccines have had, and continue to have, a major impact not only on animal health and production but also on human health through increasing safe food supplies and preventing animal-to-human transmission of infectious diseases. The continued interaction between animals and human researchers and health professionals will be of major importance for adapting new technologies, providing animal models of disease, and confronting new and emerging infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630337      PMCID: PMC1932753          DOI: 10.1128/CMR.00005-07

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  179 in total

Review 1.  Protective immune mechanisms against Theileria parva: evolution of vaccine development strategies.

Authors:  D J McKeever; E L Taracha; W I Morrison; A J Musoke; S P Morzaria
Journal:  Parasitol Today       Date:  1999-07

2.  A specific PCR to differentiate between gE negative vaccine and wildtype bovine herpesvirus type 1 strains.

Authors:  F Schynts; E Baranowski; M Lemaire; E Thiry
Journal:  Vet Microbiol       Date:  1999-04-19       Impact factor: 3.293

Review 3.  Vaccination of wildlife against rabies: successful use of a vectored vaccine obtained by recombinant technology.

Authors:  M Mackowiak; J Maki; L Motes-Kreimeyer; T Harbin; K Van Kampen
Journal:  Adv Vet Med       Date:  1999

Review 4.  Vaccination against canine babesiosis.

Authors:  Theo Schetters
Journal:  Trends Parasitol       Date:  2005-04

Review 5.  Immunity and vaccine development in the bovine theilerioses.

Authors:  N Boulter; R Hall
Journal:  Adv Parasitol       Date:  1999       Impact factor: 3.870

6.  Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine.

Authors:  E B Belknap; L M Walters; C Kelling; V K Ayers; J Norris; J McMillen; C Hayhow; M Cochran; D N Reddy; J Wright; J K Collins
Journal:  Vaccine       Date:  1999-05-04       Impact factor: 3.641

7.  Identification of an IS711 element interrupting the wboA gene of Brucella abortus vaccine strain RB51 and a PCR assay to distinguish strain RB51 from other Brucella species and strains.

Authors:  R Vemulapalli; J R McQuiston; G G Schurig; N Sriranganathan; S M Halling; S M Boyle
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

Review 8.  The immunobiology of gastrointestinal nematode infections in ruminants.

Authors:  A Balic; V M Bowles; E N Meeusen
Journal:  Adv Parasitol       Date:  2000       Impact factor: 3.870

Review 9.  Past and present vaccine development strategies for the control of foot-and-mouth disease.

Authors:  V Balamurugan; R Manoj Kumar; V V S Suryanarayana
Journal:  Acta Virol       Date:  2004       Impact factor: 1.162

Review 10.  Aujeszky's disease vaccination and differentiation of vaccinated from infected pigs.

Authors:  M Pensaert; G Labarque; H Favoreel; H Nauwynck
Journal:  Dev Biol (Basel)       Date:  2004
View more
  121 in total

1.  Amblyomma americanum (L.) (Acari: Ixodidae) tick salivary gland serine protease inhibitor (serpin) 6 is secreted into tick saliva during tick feeding.

Authors:  Katelyn Cox Chalaire; Tae Kwon Kim; Heidy Garcia-Rodriguez; Albert Mulenga
Journal:  J Exp Biol       Date:  2011-02-15       Impact factor: 3.312

2.  Expression and Purification of a Recombinant Enterotoxin Protein Using Different E. coli Host Strains and Expression Vectors.

Authors:  Hong Zhao; Yongping Xu; Xiaoyu Li; Gen Li; Haofei Zhao; Lili Wang
Journal:  Protein J       Date:  2021-03-15       Impact factor: 2.371

Review 3.  Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens.

Authors:  Aarti Rana; Shweta Thakur; Girish Kumar; Yusuf Akhter
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

Review 4.  Viruses as vaccine vectors for infectious diseases and cancer.

Authors:  Simon J Draper; Jonathan L Heeney
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

5.  Inclusion of the bovine neutrophil beta-defensin 3 with glycoprotein D of bovine herpesvirus 1 in a DNA vaccine modulates immune responses of mice and cattle.

Authors:  Sarah Mackenzie-Dyck; Jennifer Kovacs-Nolan; Marlene Snider; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

6.  Protective antibody response following oral vaccination with microencapsulated Bacillus Anthracis Sterne strain 34F2 spores.

Authors:  Jamie Benn Felix; Sankar P Chaki; Yi Xu; Thomas A Ficht; Allison C Rice-Ficht; Walter E Cook
Journal:  NPJ Vaccines       Date:  2020-07-10       Impact factor: 7.344

Review 7.  Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.

Authors:  Daniella Calderon-Nieva; Kalhari Bandara Goonewardene; Susantha Gomis; Marianna Foldvari
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

Review 8.  From the bluetongue vaccination campaigns in sheep to overimmunization and ovine ASIA syndrome.

Authors:  J Asín; M Pérez; P Pinczowski; M Gimeno; L Luján
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

9.  Genome-Wide Identification of Virulence Genes in Erysipelothrix rhusiopathiae: Use of a Mutant Deficient in a tagF Homolog as a Safe Oral Vaccine against Swine Erysipelas.

Authors:  Yoshihiro Shimoji; Yohsuke Ogawa; Manae Tsukio; Kazumasa Shiraiwa; Sayaka Nishikawa; Masahiro Eguchi
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

10.  Mutations in the Salmonella enterica serovar Choleraesuis cAMP-receptor protein gene lead to functional defects in the SPI-1 Type III secretion system.

Authors:  Zeng-Weng Chen; Shih-Ling Hsuan; Jiunn-Wang Liao; Ter-Hsin Chen; Chi-Ming Wu; Wei-Cheng Lee; Cheng-Chung Lin; Chih-Ming Liao; Kuang-Sheng Yeh; James R Winton; Chienjin Huang; Maw-Sheng Chien
Journal:  Vet Res       Date:  2009-09-24       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.